Literature DB >> 16517108

Identification and evaluation of Peruvian plants used to treat malaria and leishmaniasis.

L P Kvist1, S B Christensen, H B Rasmussen, K Mejia, A Gonzalez.   

Abstract

Households in eleven geographically and ethnically distinct areas in Loreto, Peru, were interviewed about their knowledge and use of plants, for the treatment of malaria and leishmaniasis. The survey resulted in 988 use records representing 118 plant-taxa for malaria and 289 use-records representing 85 plant-taxa for leishmaniasis. In both cases the 10 most frequently reported taxa accounted for about half of all the use-records. Plant material was collected and extracts were screened for in vitro inhibition of Plasmodium and Leishmania parasites. In the case of Plasmodium, extracts of 11 of the 13 most frequently reported plants showed significant growth inhibitory activity, while only a few plant extracts inhibited the growth of Leishmania parasites.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16517108     DOI: 10.1016/j.jep.2006.01.020

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  20 in total

Review 1.  The globalization of traditional medicine in northern peru: from shamanism to molecules.

Authors:  Rainer W Bussmann
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-28       Impact factor: 2.629

2.  Synergistic enhancement of parasiticidal activity of amphotericin B using copaiba oil in nanoemulsified carrier for oral delivery: an approach for non-toxic chemotherapy.

Authors:  Pramod K Gupta; Anil K Jaiswal; Shalini Asthana; Venkatesh Teja B; Prashant Shukla; Minakshi Shukla; Neeti Sagar; Anuradha Dube; Srikanta K Rath; Prabhat R Mishra
Journal:  Br J Pharmacol       Date:  2015-05-19       Impact factor: 8.739

3.  Antileishmanial, antitrypanosomal, and cytotoxic screening of ethnopharmacologically selected Peruvian plants.

Authors:  Azucena González-Coloma; Matías Reina; Claudia Sáenz; Rodney Lacret; Lastenia Ruiz-Mesia; Vicente J Arán; Jesús Sanz; Rafael A Martínez-Díaz
Journal:  Parasitol Res       Date:  2011-09-16       Impact factor: 2.289

4.  Sedative and anxiolytic effects of the extracts of the leaves of Stachytarpheta cayennensis in mice.

Authors:  Gbola Olayiwola; Otas Ukponmwan; Dayo Olawode
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-10-03

5.  Asháninka medicinal plants: a case study from the native community of Bajo Quimiriki, Junín, Peru.

Authors:  Gaia Luziatelli; Marten Sørensen; Ida Theilade; Per Mølgaard
Journal:  J Ethnobiol Ethnomed       Date:  2010-08-13       Impact factor: 2.733

6.  Pentalinon andrieuxii root extract is effective in the topical treatment of cutaneous leishmaniasis caused by Leishmania mexicana.

Authors:  Claudio M Lezama-Dávila; Li Pan; Angelica P Isaac-Márquez; Cesar Terrazas; Steve Oghumu; Ricardo Isaac-Márquez; M Y Pech-Dzib; Joseph Barbi; Edward Calomeni; Narasimham Parinandi; A Douglas Kinghorn; Abhay R Satoskar
Journal:  Phytother Res       Date:  2013-11-08       Impact factor: 5.878

7.  In vivo antimalarial activity of ethanolic leaf extract of Stachytarpheta cayennensis.

Authors:  Jude E Okokon; Ette Ettebong; Bassey S Antia
Journal:  Indian J Pharmacol       Date:  2008-06       Impact factor: 1.200

8.  The World Summit of Harmonization on Traditional, Alternative and Complementary Medicine (TACM) in Lima, Peru.

Authors:  Gustavo F Gonzales; José Aguilar; Martha Villar
Journal:  Evid Based Complement Alternat Med       Date:  2008-06-23       Impact factor: 2.629

Review 9.  The Potential of Traditional Knowledge to Develop Effective Medicines for the Treatment of Leishmaniasis.

Authors:  Luiz Felipe D Passero; Erika Dos Santos Brunelli; Thamara Sauini; Thais Fernanda Amorim Pavani; Jéssica Adriana Jesus; Eliana Rodrigues
Journal:  Front Pharmacol       Date:  2021-06-08       Impact factor: 5.810

10.  Amazonian Medicine and the Psychedelic Revival: Considering the "Dieta".

Authors:  David M O'Shaughnessy; Ilana Berlowitz
Journal:  Front Pharmacol       Date:  2021-05-28       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.